Wagner J, Olson ND, Harris L, McDaniel J, Cheng H, Fungtammasan A, et al. Curated variation benchmarks for challenging medically relevant autosomal genes. Nat Biotechnol. 2022;40(5):672–80.

Article  PubMed  PubMed Central  Google Scholar 

Ebbert MTW, Jensen TD, Jansen-West K, Sens JP, Reddy JS, Ridge PG, et al. Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight. Genome Biol. 2019;20(1):97.

Article  PubMed  PubMed Central  Google Scholar 

Ryan DP, da Silva MRD, Soong TW, Fontaine B, Donaldson MR, Kung AWC, et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell. 2010;140(1):88–98.

Article  PubMed  PubMed Central  Google Scholar 

Chaisson MJP, Wilson RK, Eichler EE. Genetic variation and the de novo assembly of human genomes. Nat Rev Genet. 2015;16(11):627–40.

Article  PubMed  PubMed Central  Google Scholar 

Kirby A, Gnirke A, Jaffe DB, Bareov. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet 2013;45(3):299–303.

Guo X, Zheng S, Dang H, Pace RG, Stonebraker JR, Jones CD, et al. Genome reference and sequence variation in the large repetitive central exon of human MUC5AC. Am J Respir Cell Mol Biol. 2014;50(1):223–32.

Article  PubMed  PubMed Central  Google Scholar 

Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. The complete sequence of a human genome. Science. 2022;376(6588):44–53.

Article  PubMed  PubMed Central  Google Scholar 

Jain C, Rhie A, Hansen N, Koren S, Phillippy AM. A long read mapping method for highly repetitive reference sequences. bioRxiv 2020:2020.11.01.363887.

Aganezov S, Yan SM, Soto DC, Kirsche M, Zarate S, Avdeyev P, et al. A complete reference genome improves analysis of human genetic variation. Science. 2022;376(6588):eabl3533.

Article  PubMed  PubMed Central  Google Scholar 

Ebert P, Audano PA, Zhu Q, Rodriguez-Martin B, Porubsky D, Bonder MJ, et al. Haplotype-resolved diverse human genomes and integrated analysis of structural variation. Science. 2021;372(6537):eabf7117.

Article  PubMed  PubMed Central  Google Scholar 

Behera S, Belyeu JR, Chen X, Paulin LF, Nguyen NQH, Newman E, et al. Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. bioRxiv 2023:2023.04.24.538128.

Sedlazeck FJ, Lee H, Darby CA, Schatz MC. Piercing the dark matter: bioinformatics of long-range sequencing and mapping. Nat Rev Genet. 2018;19(6):329–46.

Article  PubMed  Google Scholar 

Behera S, Catreux S, Rossi M, Truong S, Huang Z, Ruehle M, et al. Comprehensive and accurate genome analysis at scale using DRAGEN accelerated algorithms. bioRxiv 2024:2024.01.02.573821.

De Coster W, Weissensteiner MH, Sedlazeck FJ. Towards population-scale long-read sequencing. Nat Rev Genet. 2021;22(9):572–87.

Article  PubMed  PubMed Central  Google Scholar 

Coassin S, Kronenberg F. Lipoprotein(a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene. Atherosclerosis. 2022;349:17–35.

Article  PubMed  PubMed Central  Google Scholar 

Kronenberg F, Utermann G. Lipoprotein(a): resurrected by genetics. J Intern Med. 2013;273(1):6–30.

Article  PubMed  Google Scholar 

Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925–46.

Article  PubMed  PubMed Central  Google Scholar 

Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2021;42(2):e48–60.

PubMed  PubMed Central  Google Scholar 

Arsenault BJ, Kamstrup PR. Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective. Atherosclerosis. 2022;349:7–16.

Article  PubMed  Google Scholar 

Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, et al. Lp(a) (lipoprotein a) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank. Arterioscler Thromb Vasc Biol. 2021;41(1):465–74.

Article  PubMed  Google Scholar 

Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation. 2008;117(2):176–84.

Article  PubMed  Google Scholar 

Enkhmaa B, Anuurad E, Berglund L. Lipoprotein (a): impact by ethnicity and environmental and medical conditions. J Lipid Res. 2016;57(7):1111–25.

Article  PubMed  PubMed Central  Google Scholar 

Schmidt K, Noureen A, Kronenberg F, Utermann G. Structure, function, and genetics of lipoprotein (a). J Lipid Res. 2016;57(8):1339–59.

Article  PubMed  PubMed Central  Google Scholar 

Coassin S, Schönherr S, Weissensteiner H, Erhart G, Forer L, Losso JL, et al. A comprehensive map of single-base polymorphisms in the hypervariable LPA kringle IV type 2 copy number variation region. J Lipid Res. 2019;60(1):186–99.

Article  PubMed  Google Scholar 

Coassin S, Erhart G, Weissensteiner H, de Arajo MEG, Lamina C, Schönherr S, et al. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction. Eur Heart J. 2017;38(23):1823–31.

Article  PubMed  PubMed Central  Google Scholar 

Schachtl-Riess JF, Kheirkhah A, Grüneis R, Di Maio S, Schoenherr S, Streiter G, et al. Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease. J Am Coll Cardiol. 2021;78(5):437–49.

Article  PubMed  PubMed Central  Google Scholar 

Mukamel RE, Handsaker RE, Sherman MA, Barton AR, Zheng Y, McCarroll SA, et al. Protein-coding repeat polymorphisms strongly shape diverse human phenotypes. Science. 2021;373(6562):1499–505.

Article  PubMed  PubMed Central  Google Scholar 

Di Maio S, Grüneis R, Streiter G, Lamina C, Maglione M, Schoenherr S, et al. Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals. Genome Med. 2020;12(1):74.

Article  PubMed  PubMed Central  Google Scholar 

McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330(6144):132–7.

Article  PubMed  Google Scholar 

Noureen A, Fresser F, Utermann G, Schmidt K. Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations. PLoS ONE. 2015;10(3): e0121582.

Article  PubMed  PubMed Central  Google Scholar 

Deamer D, Akeson M, Branton D. Three decades of nanopore sequencing. Nat Biotechnol. 2016;34(5):518–24.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhao Y, Bollas A, Wang Y, Au KF. Nanopore sequencing technology, bioinformatics and applications. Nat Biotechnol. 2021;39(11):1348–65.

Article  PubMed  PubMed Central  Google Scholar 

Zurek PJ, Knyphausen P, Neufeld K, Pushpanath A, Hollfelder F. UMI-linked consensus sequencing enables phylogenetic analysis of directed evolution. Nat Commun. 2020;11(1):6023.

Article  PubMed  PubMed Central  Google Scholar 

Karst SM, Ziels RM, Kirkegaard RH, Sorensen EA, McDonald D, Zhu Q, et al. High-accuracy long-read amplicon sequences using unique molecular identifiers with nanopore or PacBio sequencing. Nat Methods. 2021;18(2):165–9.

Article  PubMed  Google Scholar 

Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.

Article  PubMed